Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

APOA2 anticorps

APOA2 Reactivité: Humain WB, IHC (p), IP, IHC (fro), EIA Hôte: Chèvre Polyclonal unconjugated
N° du produit ABIN116542
  • Antigène Voir toutes APOA2 Anticorps
    APOA2 (Apolipoprotein A-II (APOA2))
    Reactivité
    • 79
    • 37
    • 13
    • 9
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 67
    • 12
    • 7
    • 2
    • 2
    • 1
    Chèvre
    Clonalité
    • 75
    • 16
    Polyclonal
    Conjugué
    • 38
    • 12
    • 8
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp APOA2 est non-conjugé
    Application
    • 43
    • 31
    • 25
    • 14
    • 13
    • 9
    • 9
    • 9
    • 8
    • 7
    • 6
    • 4
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunoprecipitation (IP), Immunohistochemistry (Frozen Sections) (IHC (fro)), Enzyme Immunoassay (EIA)
    Specificité
    This product has been prepared by Immunoaffinity Chromatography using immobilized antigens followed by extensive cross-adsorption against other apoLipoproteins and human serum proteins to remove any unwanted specificities. Typically less than 1 % cross reactivity against other types of apoLipoprotein was detected by ELISA against purified standards. This antibody reacts with ApoLipoprotein A-II and has negligible cross-reactivity with Type A-I, B, C-I, C-II, C-III, E and J apoLipoproteins. Non-specific cross reaction of anti-apoLipoprotein antibodies with other Human serum proteins is negligible.
    Purification
    Immunoaffinity Chromatography.
    Immunogène
    ApoLipoprotein Type A-II was isolated from Human plasma by Density Gradient Centrifugation followed by HPLC purification.
    Top Product
    Discover our top product APOA2 Anticorps primaire
  • Indications d'application
    This Apo AII antibody R1031P has been used for indirect trapping ELISA for quantitation ofantigen in serum using a standard curve, for Immunoprecipitation and Western blotting forhighly sensitive qualitative analysis. Recommended Dilutions: ELISA: 1/5,000-1/10,000. Immunoprecipitation: 1/100. Western blot: 1/5,000-1/10,000. Immunohistochemistry: 1: /50-1/200.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.
    Restrictions
    For Research Use only
  • Concentration
    1.0 mg/mL (by UV absorbance at 280 nm)
    Buffer
    0.125 M Sodium Borate, 0.075 M Sodium Chloride, 0.005 M EDTA, pH 8.0 and 0.01 % Sodium Azide as preservative.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Conseil sur la manipulation
    Avoid repeated freezing and thawing. This product is photosensitive and should be protected from light
    Stock
    4 °C/-20 °C
    Stockage commentaire
    Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
  • Antigène
    APOA2 (Apolipoprotein A-II (APOA2))
    Autre désignation
    Apolipoprotein A II (Apo AII) (APOA2 Produits)
    Synonymes
    anticorps Apo-AII, anticorps ApoA-II, anticorps apoAII, anticorps Alp-2, anticorps ApoAII, anticorps Apoa-2, anticorps Hdl-1, anticorps APOAII, anticorps apoa2, anticorps apoA-II, anticorps cb1032, anticorps wu:fb57h11, anticorps zgc:193613, anticorps apolipoprotein A2, anticorps apolipoprotein A-II, anticorps APOA2, anticorps Apoa2, anticorps apoa2
    Sujet
    Apolipoprotein A II is the second most abundant protein of the high density lipoprotein particles. The apolipoprotein A II gene consists of 4 exons and 3 introns. The four exons encode the 5' untranslated region, pre peptide, a short N terminal domain and a C terminal domain composed of a variable number of lipid binding amphipathic helices. Familial apolipoprotein A II deficiency may result from a splice junction alteration which blocks splicing of intron 3 from the primary transcript and result in the formation of a non functional mRNA.Synonyms: APOA2, Apo-AII, ApoA-II, Apolipoprotein A-II, Apolipoprotein A2
    ID gène
    336
    NCBI Accession
    NP_001634
    UniProt
    P02652
    Pathways
    Regulation of Lipid Metabolism by PPARalpha, Production of Molecular Mediator of Immune Response, Negative Regulation of Transporter Activity, Lipid Metabolism
Vous êtes ici:
Support technique